RUO优妥尤单抗是一种全人源IgG 2激动剂mAb,可选择性结合人4- 1 BB/CD 137,导致细胞系和原代淋巴细胞中NF-κB活化和下游细胞因子产生。优妥尤单抗可诱导人白细胞增殖,并在人外周血淋巴细胞(PBL)SCID异种移植肿瘤模型中作为单药显示出显著的抗肿瘤活性。 优妥尤单抗生物仿制药-研究级该产品同种型对照:Bulk Human IgG2 Isotype Control (IB2) [ICH2255] 缓冲液:ICH3002 浓度:5mg/ml 纯度:>95% by SDS-PAGE 内毒素:≤ 1.0 EU/mg as determined by the LAL method 制剂:Sterile, preservative-free, solution in PBS. BSA and Azide free.